Epividian, Inc.

Epividian, Inc. is a biotechnology and healthcare startup founded in 2012, based in the United States. The company's slogan "Advancing the Mission of Medicine!" reflects its dedication to improving health outcomes through novel research services. Epividian's unique approach involves leveraging real-world clinical data from various healthcare settings to support clinical research, academic pursuits, public health initiatives, and regulatory endeavors. The company's flagship product, the OPERA® database and research network, is a comprehensive observational database comprising patient health records from over 400 participating caregivers across 54 U.S. cities. Notably, this database includes detailed information on nearly 930,000 patients, with a focus on HIV-positive individuals, representing about 8% of all HIV+ patients linked to care in the U.S. The continuous refresh of data from electronic health record systems ensures that OPERA® is the largest continuously operating cohort of HIV+ patients in the country. Epividian not only provides clinicians with analytical reports and research services for patient care and population management but also supports their involvement in clinical trials and non-interventional studies using the OPERA® database. The company's dedication to bridging the gap between clinical medicine and research is evident in its commitment to improving the doctor-patient relationship, monitoring for potential side effects, and enhancing public health through the impact of interventions. Epividian's focus on utilizing longitudinal observational data to facilitate sophisticated research aligns with the current trends in healthcare and data-driven decision-making. As the company continues to advance the mission of medicine, it presents an intriguing opportunity for potential investors seeking to support innovative solutions that contribute to the improvement of healthcare outcomes and the advancement of medical research.